Literature DB >> 34731647

Mice with diverse microbial exposure histories as a model for preclinical vaccine testing.

Jessica K Fiege1, Katharine E Block2, Mark J Pierson2, Hezkiel Nanda3, Frances K Shepherd1, Clayton K Mickelson1, J Michael Stolley1, William E Matchett1, Sathi Wijeyesinghe1, David K Meyerholz4, Vaiva Vezys1, Steven S Shen3, Sara E Hamilton5, David Masopust6, Ryan A Langlois7.   

Abstract

Laboratory mice comprise an expeditious model for preclinical vaccine testing; however, vaccine immunogenicity in these models often inadequately translates to humans. Reconstituting physiologic microbial experience to specific pathogen-free (SPF) mice induces durable immunological changes that better recapitulate human immunity. We examined whether mice with diverse microbial experience better model human responses post vaccination. We co-housed laboratory mice with pet-store mice, which have varied microbial exposures, and then assessed immune responses to influenza vaccines. Human transcriptional responses to influenza vaccination are better recapitulated in co-housed mice. Although SPF and co-housed mice were comparably susceptible to acute influenza infection, vaccine-induced humoral responses were dampened in co-housed mice, resulting in poor control upon challenge. Additionally, protective heterosubtypic T cell immunity was compromised in co-housed mice. Because SPF mice exaggerated humoral and T cell protection upon influenza vaccination, reconstituting microbial experience in laboratory mice through co-housing may better inform preclinical vaccine testing.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  T cell immunity; dirty mice; humoral immunity; influenza virus; preclinical models; vaccine

Mesh:

Substances:

Year:  2021        PMID: 34731647      PMCID: PMC8665115          DOI: 10.1016/j.chom.2021.10.001

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  70 in total

1.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features.

Authors:  Yang Liao; Gordon K Smyth; Wei Shi
Journal:  Bioinformatics       Date:  2013-11-13       Impact factor: 6.937

Review 2.  Experimental infection of human volunteers.

Authors:  Meta Roestenberg; Marie-Astrid Hoogerwerf; Daniela M Ferreira; Benjamin Mordmüller; Maria Yazdanbakhsh
Journal:  Lancet Infect Dis       Date:  2018-06-18       Impact factor: 25.071

Review 3.  Of mice and not men: differences between mouse and human immunology.

Authors:  Javier Mestas; Christopher C W Hughes
Journal:  J Immunol       Date:  2004-03-01       Impact factor: 5.422

Review 4.  Immunogenicity and adverse events of avian influenza A H5N1 vaccine in healthy adults: multiple-treatments meta-analysis.

Authors:  Lamberto Manzoli; Georgia Salanti; Corrado De Vito; Antonio Boccia; John P A Ioannidis; Paolo Villari
Journal:  Lancet Infect Dis       Date:  2009-08       Impact factor: 25.071

5.  Genomic responses in mouse models poorly mimic human inflammatory diseases.

Authors:  Junhee Seok; H Shaw Warren; Alex G Cuenca; Michael N Mindrinos; Henry V Baker; Weihong Xu; Daniel R Richards; Grace P McDonald-Smith; Hong Gao; Laura Hennessy; Celeste C Finnerty; Cecilia M López; Shari Honari; Ernest E Moore; Joseph P Minei; Joseph Cuschieri; Paul E Bankey; Jeffrey L Johnson; Jason Sperry; Avery B Nathens; Timothy R Billiar; Michael A West; Marc G Jeschke; Matthew B Klein; Richard L Gamelli; Nicole S Gibran; Bernard H Brownstein; Carol Miller-Graziano; Steve E Calvano; Philip H Mason; J Perren Cobb; Laurence G Rahme; Stephen F Lowry; Ronald V Maier; Lyle L Moldawer; David N Herndon; Ronald W Davis; Wenzhong Xiao; Ronald G Tompkins
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-11       Impact factor: 11.205

6.  Rewilding Nod2 and Atg16l1 Mutant Mice Uncovers Genetic and Environmental Contributions to Microbial Responses and Immune Cell Composition.

Authors:  Jian-Da Lin; Joseph C Devlin; Frank Yeung; Caroline McCauley; Jacqueline M Leung; Ying-Han Chen; Alex Cronkite; Christina Hansen; Charlotte Drake-Dunn; Kelly V Ruggles; Ken Cadwell; Andrea L Graham; P'ng Loke
Journal:  Cell Host Microbe       Date:  2020-03-24       Impact factor: 21.023

Review 7.  Improving influenza vaccines: challenges to effective implementation.

Authors:  Fan Zhou; Mai-Chi Trieu; Richard Davies; Rebecca Jane Cox
Journal:  Curr Opin Immunol       Date:  2018-04-30       Impact factor: 7.486

Review 8.  AS03- and MF59-Adjuvanted Influenza Vaccines in Children.

Authors:  Amanda L Wilkins; Dmitri Kazmin; Giorgio Napolitani; Elizabeth A Clutterbuck; Bali Pulendran; Claire-Anne Siegrist; Andrew J Pollard
Journal:  Front Immunol       Date:  2017-12-13       Impact factor: 7.561

Review 9.  The Future of Influenza Vaccines: A Historical and Clinical Perspective.

Authors:  Nicole M Bouvier
Journal:  Vaccines (Basel)       Date:  2018-08-30

Review 10.  Causes of impaired oral vaccine efficacy in developing countries.

Authors:  Edward Pk Parker; Sasirekha Ramani; Benjamin A Lopman; James A Church; Miren Iturriza-Gómara; Andrew J Prendergast; Nicholas C Grassly
Journal:  Future Microbiol       Date:  2017-12-08       Impact factor: 3.165

View more
  11 in total

1.  Effect of gluten-free diet and antibiotics on murine gut microbiota and immune response to tetanus vaccination.

Authors:  Pernille Kihl; Lukasz Krych; Ling Deng; Lars H Hansen; Karsten Buschard; Søren Skov; Dennis S Nielsen; Axel Kornerup Hansen
Journal:  PLoS One       Date:  2022-04-13       Impact factor: 3.240

Review 2.  From germ-free to wild: modulating microbiome complexity to understand mucosal immunology.

Authors:  Carolyn A Thomson; Sydney C Morgan; Christina Ohland; Kathy D McCoy
Journal:  Mucosal Immunol       Date:  2022-09-05       Impact factor: 8.701

Review 3.  Integrating complex host-pathogen immune environments into S. aureus vaccine studies.

Authors:  Chih-Ming Tsai; Irshad A Hajam; J R Caldera; George Y Liu
Journal:  Cell Chem Biol       Date:  2022-05-19       Impact factor: 9.039

4.  Advancing Lung Immunology Research: An Official American Thoracic Society Workshop Report.

Authors:  Rod A Rahimi; Josalyn L Cho; Claudia V Jakubzick; Shabaana A Khader; Bart N Lambrecht; Clare M Lloyd; Ari B Molofsky; Sebastien Talbot; Catherine A Bonham; Wonder P Drake; Anne I Sperling; Benjamin D Singer
Journal:  Am J Respir Cell Mol Biol       Date:  2022-07       Impact factor: 7.748

5.  mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2.

Authors:  Tamarand L Darling; Baoling Ying; Bradley Whitener; Laura A VanBlargan; Traci L Bricker; Chieh-Yu Liang; Astha Joshi; Gayan Bamunuarachchi; Kuljeet Seehra; Aaron J Schmitz; Peter J Halfmann; Yoshihiro Kawaoka; Sayda M Elbashir; Darin K Edwards; Larissa B Thackray; Michael S Diamond; Adrianus C M Boon
Journal:  Med (N Y)       Date:  2022-04-15

Review 6.  The Influence of Genetic and Environmental Factors and Their Interactions on Immune Response to Helminth Infections.

Authors:  Oyebola O Oyesola; Camila Oliveira Silva Souza; P'ng Loke
Journal:  Front Immunol       Date:  2022-04-29       Impact factor: 8.786

7.  Caught in a trap: How pre-clinical studies in laboratory mice exaggerate vaccine responses.

Authors:  Lynda Coughlan
Journal:  Cell Rep Med       Date:  2021-12-21

Review 8.  Mechanisms of SARS-CoV-2 entry into cells.

Authors:  Cody B Jackson; Michael Farzan; Bing Chen; Hyeryun Choe
Journal:  Nat Rev Mol Cell Biol       Date:  2021-10-05       Impact factor: 94.444

Review 9.  Immune Responses to IAV Infection and the Roles of L-Selectin and ADAM17 in Lymphocyte Homing.

Authors:  Sophie G Reed; Ann Ager
Journal:  Pathogens       Date:  2022-01-25

10.  Polymer formulated self-amplifying RNA vaccine is partially protective against influenza virus infection in ferrets.

Authors:  P F McKay; J Zhou; R Frise; A K Blakney; C R Bouton; Z Wang; K Hu; K Samnuan; J C Brown; R Kugathasan; J Yeow; M M Stevens; W S Barclay; J S Tregoning; R J Shattock
Journal:  Oxf Open Immunol       Date:  2022-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.